ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent
This fresh infusion of capital will enable ImmunoACT to fast track the additional supply of the lead candidate HCAR-19
The business and product range of Ipca and that of Unichem complements each others business and product range
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
Subscribe To Our Newsletter & Stay Updated
